Skip to Main Content

Paper Details

High frequency of antidrug antibodies and association of random drug levels with efficacy in certolizumab pegol-treated patients with rheumatoid arthritis: results from the BRAGGSS cohort.
Annals of the Rheumatic Diseases
41
2017
ADAbs, Patient, RA, Rheumatism, certolizumab, certolizumab pegol, patient, patients, rheumatoid arthritis, serum
Author NameAffiliation
Ann W MorganLeeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and National Institute of Health Research Leeds Musculoskeletal Biomedical Research Unit, Leeds Teaching Hospitals NHS Trust
Anthony G WilsonUniversity College of Dublin School of Medicine and Medical Science
Anne BartonInstitute of Inflammation and Repair, University of Manchester
Anne BartonNational Institute of Health Research Manchester Musculoskeletal Biomedical Research Unit, Central Manchester Foundation Trust
  • 1 - 4

Datasets

Release 1.2